Table 2 Demographics and baseline clinical characteristics
|  | Vojta group (n = 20) | Control group (n = 20) |
|---|---|---|
Sex | ||
 Female | 11 (55%) | 9 (45%) |
 Male | 9 (45%) | 11 (55%) |
Age, median (IQR) | 77 (72.5–85) | 72.5 (64–78) |
Risk factors | ||
 Hypertension | 15 (75%) | 16 (80%) |
 Diabetes mellitus | 5 (25%) | 3 (15%) |
 Smokera | 3 (15%) | 4 (20%) |
 Artrial fibrillation | 4 (20%) | 3 (15%) |
 Orthopaedic diseaseb | 9 (45%) | 1 (5%) |
Right handedness | 20 (100%) | 19 (95%) |
Prior stroke | 5 (25%) | 7 (35%) |
Premorbid history | ||
 Premorbid mRS, median (IQR) | 0 (0–2) | 0·(0–1.5) |
 Premorbid mRS, mean (SD) | 0.9 (1.25) | 0.65 (1.09) |
 Walking without aid | 14 (70%) | 16 (80%) |
Stroke history | ||
 Ischaemic stroke | 20 (100%) | 19 (95%) |
 Haemorrhagic stroke | 0 (0%) | 1 (5%) |
 Left MCA infarct | 2 (10%) | 8 (42%) |
 Right MCA infarct | 17 (85%) | 10 (53%) |
 Brainstem infarct | 1 (5%) | 0 (0%) |
 Other or multiple locationsc | 0 (0%) | 1 (5%) |
 NIHSS at admission | 14.5 (12–16) | 12 (8.5–15) |
 rtPA treatment administered | 8 (40%) | 5 (26%) |
 Thrombectomy performed | 7 (35%) | 5 (26%) |
 Patients with neglect | 16 (80%) | 11 (55%) |
Scores at baseline, median (IQR) | ||
 Trunk control test | 25 (0–43) | 56 (42.5–87) |
 MESUPES | 2 (0–5.0) | 3 (1–10.5) |
 CBS | 4 (3–5.5) | 3 (2–4) |
 modified Rankin Scale | 5 (4–5) | 4 (4–5) |
 Barthel Index | 3 (0–3.5) | 5 (1–9) |
 NIHSS after randomisation | 15 (12.5–16.5) | 11.5 (10–14.9) |